[Business Wire] - Synageva BioPharma Corp. , a biopharmaceutical company developing therapeutic products for rare disorders, today announced the pricing of its previously announced underwritten public offering of common stock consisting of 2.75 million shares at $56.63 per share.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment